Suren G. Dutia - 22 Jul 2021 Form 4 Insider Report for Citius Pharmaceuticals, Inc. (CTXR)

Role
Director
Signature
/s/ Alexander M. Donaldson, by power of attorney
Issuer symbol
CTXR
Transactions as of
22 Jul 2021
Net transactions value
$0
Form type
4
Filing time
26 Jul 2021, 17:03:24 UTC
Next filing
13 Oct 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTXR Options to Purchase Common Stock Award $0 +15,000 $0.000000 15,000 22 Jul 2021 Common Stock 15,000 $2.00 Direct F1
holding CTXR Options to Purchase Common Stock 25,000 22 Jul 2021 Common Stock 25,000 $1.69 Direct F2
holding CTXR Options to Purchase Common Stock 35,000 22 Jul 2021 Common Stock 35,000 $1.01 Direct F3
holding CTXR Options to Purchase Common Stock 25,000 22 Jul 2021 Common Stock 25,000 $1.39 Direct F4
holding CTXR Options to Purchase Common Stock 25,000 22 Jul 2021 Common Stock 25,000 $0.6700 Direct F5
holding CTXR Options to Purchase Common Stock 15,000 22 Jul 2021 Common Stock 15,000 $1.62 Direct F6
holding CTXR Options to Purchase Common Stock 10,000 22 Jul 2021 Common Stock 10,000 $3.45 Direct F7
holding CTXR Options to Purchase Common Stock 26,667 22 Jul 2021 Common Stock 26,667 $8.10 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options vest in full on July 22, 2022.
F2 The options vest in full on February 16, 2022.
F3 The options vest in full on October 6, 2021.
F4 The options vest in full on July 7, 2021.
F5 The options vest in full on October 8, 2020.
F6 The options vest in full on September 4, 2019.
F7 The options vest in full on September 13, 2018.
F8 The options granted vested and became exercisable as follows: the option to purchase 2,667 shares of common stock of the Company (the "Common Stock") vested on October 1, 2015, and the balance of the option to purchase shares of Common Stock vested in twelve (12) equal installments commencing on December 31, 2015.